Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
Annals of Surgical Oncology|May 22, 2014
Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysisAslam Ejaz, Gaya Spolverato, Yuhree Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2021
Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image GuidanceJoshua S Niedzielski, Yufei Liu, Sylvia S W Ng, et al.
Annals of Surgical Oncology|October 25, 2017
Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and EffectiveJohn F Ryan, Vincent P Groot, Lauren M Rosati, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Practical Radiation Oncology|June 4, 2014
Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensusSalma K Jabbour, Sameh A Hashem, Walter Bosch, et al.
Cancer|May 31, 2013
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerEdward J Kim, Edgar Ben-Josef, Joseph M Herman, et al.
Gynecologic Oncology|January 23, 2017
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A Reiss, Joseph M Herman, Deborah Armstrong, et al.
International Journal of Surgical Oncology|July 26, 2012
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal CancerJessica A Smith, Aaron T Wild, Aatur Singhi, et al.
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Annals of Surgical Oncology|May 22, 2014
Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysisAslam Ejaz, Gaya Spolverato, Yuhree Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2021
Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image GuidanceJoshua S Niedzielski, Yufei Liu, Sylvia S W Ng, et al.
Annals of Surgical Oncology|October 25, 2017
Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and EffectiveJohn F Ryan, Vincent P Groot, Lauren M Rosati, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Practical Radiation Oncology|June 4, 2014
Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensusSalma K Jabbour, Sameh A Hashem, Walter Bosch, et al.
Cancer|May 31, 2013
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerEdward J Kim, Edgar Ben-Josef, Joseph M Herman, et al.
Gynecologic Oncology|January 23, 2017
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A Reiss, Joseph M Herman, Deborah Armstrong, et al.
International Journal of Surgical Oncology|July 26, 2012
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal CancerJessica A Smith, Aaron T Wild, Aatur Singhi, et al.
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
Pageof 32